195 FontanaA.Polverino De LauretoP.De FilippisV.ScaramellaE.ZamboninM
BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review
Recalls & Warnings January 24, 2003 FTC Challenges Weight-loss Claims for Slim Down Solution The Federal Trade Commission today charged Slim Down Solution, LLC, Maderia Management, Inc., and several related companies and individuals with using false and unsubstantiated claims in the marketing and advertising of "Slim Down Solution" - a purported weight-loss product
Patients new to self-injection should receive training from their medical team
The oral route of drug delivery is challenging for peptides because the GI tract is specifically designed to break down proteins and peptides into their constituent amino acids for absorption
BPC-157 is not a specifically named WADA substance, but athletes should not assume that means it is cleared, since broad catch-all categories can apply